Your body kills bacteria through a layered defense system that starts before germs even reach your bloodstream. White blood cells physically swallow and digest invaders, proteins in your blood punch holes in bacterial membranes, your stomach dissolves most pathogens in acid, and trillions of friendly bacteria crowd out harmful ones. When these natural defenses aren’t enough, antibiotics and newer therapies step in to finish the job.
White Blood Cells: Your Primary Bacterial Killers
The most direct way your body destroys bacteria is through specialized white blood cells called phagocytes, which include neutrophils and macrophages. These cells patrol your blood and tissues looking for anything that doesn’t belong. When they detect a bacterium, they extend arm-like projections around it, forming a cup-shaped depression in their membrane that gradually closes around the invader. Within minutes, the bacterium is sealed inside a tiny internal compartment called a phagosome.
What happens next is remarkably aggressive. The phagosome fuses with another compartment loaded with digestive enzymes and toxic chemicals, creating what researchers call “the ultimate microbicidal organelle.” The interior drops to a pH of 4.5, roughly as acidic as a lemon. Enzymes break down bacterial proteins and fats. A molecule called lactoferrin starves the bacterium by stripping away the iron it needs to survive. Perhaps most destructively, an enzyme generates superoxide, which triggers a chain reaction producing hydrogen peroxide, hydroxyl radicals, and even hypochlorous acid, essentially the active ingredient in bleach. The bacterium is chemically dismantled.
Once the bacteria are digested, fragments of the dead microbe move to the surface of the phagocyte. This is a signal to the adaptive immune system, the slower but more precise branch of your defenses, telling it exactly what the threat looks like so it can mount a targeted response.
Antibodies Tag Bacteria for Destruction
Your adaptive immune system produces antibodies, Y-shaped proteins that circulate in your bloodstream and lock onto specific bacteria like a key fitting a lock. Each antibody recognizes only one type of antigen, a surface marker unique to a particular pathogen.
Antibodies kill or neutralize bacteria in three ways. They can attach directly to the bacterial surface and block the bacterium from latching onto your cells, preventing infection from spreading. They coat the bacterium in a process that makes it far easier for phagocytes to grab and consume it. And they activate a cascade of helper proteins called the complement system, which has its own lethal mechanism.
The Complement System Punches Holes in Bacteria
The complement system is a group of proteins dissolved in your blood and body fluids that, when triggered, assemble into a weapon called the membrane attack complex (MAC). This structure physically punches ring-shaped pores into bacterial membranes. Each pore measures about 10 nanometers across and 17 nanometers wide, large enough to breach both the outer and inner membranes of bacteria. Once perforated, the bacterium can’t maintain its internal environment and dies.
The process works like a chain reaction. After antibodies or pattern-recognition molecules flag a foreign cell, complement proteins organize into enzymes that cleave a precursor protein called C5. This triggers a sequence where proteins C7, C8, and up to 18 copies of C9 assemble on the bacterial surface into the completed pore. Atomic force microscopy has captured images of bacterial surfaces covered in these nanometer-scale pores after complement activation.
Stomach Acid as a First-Line Barrier
Before bacteria ever reach your intestines, your stomach acid eliminates most of them. Gastric acid typically sits at a pH between 1.5 and 3.5, an environment hostile to the majority of pathogens. Many disease-causing bacteria are highly sensitive to this acidity. Campylobacter jejuni and Vibrio cholerae, for example, are killed at pH 5.0, well above normal stomach acidity.
Not all bacteria are equally vulnerable, though. Salmonella can survive at pH levels down to about 2.6 under certain conditions, particularly when shielded by food particles. E. coli O157:H7 and Shigella flexneri can endure extreme acid at pH 2.5 or lower for hours. Yersinia enterocolitica tolerates a pH below 1.5 in laboratory conditions. This is why some foodborne pathogens cause illness despite the stomach’s defenses: they’ve evolved to survive the acid bath.
Friendly Bacteria Block Invaders
Your gut is home to trillions of bacteria that actively prevent harmful species from gaining a foothold, a phenomenon called colonization resistance. This works through several mechanisms. Resident bacteria compete aggressively with pathogens for the carbon, nitrogen, iron, and zinc they need to grow. According to the nutrient niche theory, first described by microbiologist Rolf Freter in 1983, a pathogen can only colonize the intestine if it can use at least one limiting nutrient more efficiently than the bacteria already living there. In a healthy, diverse gut microbiome, those niches are fully occupied.
Some gut bacteria also produce small antimicrobial peptides called bacteriocins that directly inhibit pathogen growth. Others generate metabolic byproducts that create an inhospitable chemical environment for invaders. This is why antibiotic treatment, while killing harmful bacteria, can paradoxically increase your vulnerability to new infections. Broad-spectrum antibiotics cause significant drops in the abundance and diversity of gut commensals, freeing up nutrients and space that pathogens exploit.
Fever Slows Bacterial Growth
Fever isn’t just a symptom of infection. It’s an active defense strategy. Every microbe has an upper temperature limit beyond which it can’t replicate or survive. When your body raises its temperature in response to infection, it’s attempting to push into that thermal exclusion zone.
This principle is well documented. An analysis of fungal strains found that between 30°C and 44°C, each one-degree increase inhibited roughly 6% more species. Most marine bacteria can’t tolerate temperatures above 25°C, far below human body temperature. For bacteria that infect humans, the margins are tighter, but fever still provides an edge. A temperature of 40.6°C (about 105°F) was historically used in clinical “fever therapy” to treat syphilis and gonorrhea before antibiotics existed, and the treatment worked well enough that its developer won the Nobel Prize in 1927.
Beyond direct thermal restriction, fever enhances immune function. Elevated body temperature increases the ability of neutrophils to generate their oxidative burst (the chemical attack described earlier) and helps them migrate more effectively into infected tissues.
How Antibiotics Kill Bacteria
When your immune system can’t clear an infection on its own, antibiotics target bacteria through mechanisms your body doesn’t have. The major classes work in three fundamentally different ways.
Destroying the cell wall. Bacteria are surrounded by a rigid wall made of a sugar-protein mesh called peptidoglycan. Beta-lactam antibiotics, including penicillins, mimic part of the building material bacteria use to construct this wall. They bind to the construction enzymes, blocking them from cross-linking the wall’s components. Without a structurally sound wall, the bacterium bursts. Glycopeptide antibiotics like vancomycin use a different approach: they physically bind to the wall’s building blocks, making them too bulky to be assembled.
Stopping protein production. Bacteria need to constantly build proteins to survive. Several antibiotic classes, including macrolides and oxazolidinones, attach to bacterial ribosomes (the molecular machines that assemble proteins) and either block incoming raw materials or cause incomplete protein chains to fall off prematurely. Human ribosomes are structurally different enough that these drugs leave your cells unharmed.
Blocking DNA replication. Fluoroquinolones disable an enzyme bacteria need to unwind and copy their DNA. Without functional DNA replication, the bacterium can’t divide or repair itself.
Antibiotic Resistance Is Narrowing Options
Some bacteria have evolved defenses against every available antibiotic. The World Health Organization’s 2024 priority pathogens list identifies 24 dangerous bacterial pathogens across 15 families, categorized into critical, high, and medium priority groups. The most alarming are gram-negative bacteria resistant to last-resort antibiotics, drug-resistant tuberculosis, and high-burden pathogens like Salmonella, Pseudomonas aeruginosa, and Staphylococcus aureus. These resistant strains are especially dangerous because, once they evade your immune system, the usual pharmaceutical backup plans don’t work.
Phage Therapy: Viruses That Kill Bacteria
One of the most promising alternatives to antibiotics uses bacteriophages, viruses that naturally prey on bacteria. Lytic phages attach to a specific bacterial species, inject their genetic material, hijack the bacterium’s machinery to make copies of themselves, and then burst the cell open.
Phage therapy has three distinct advantages. First, phages are highly specific, killing only the target species and leaving beneficial bacteria intact. Second, some phages exploit the very mechanisms bacteria use to resist antibiotics. Certain drug-resistant bacteria rely on membrane pumps to flush out antibiotics, and specific phages use those same pumps as entry points. By targeting the pump, phages force bacteria into a lose-lose situation: keep the pump and get infected by the phage, or lose the pump and become vulnerable to antibiotics again. Third, phages can penetrate bacterial biofilms, dense communities of bacteria that are roughly 1,000 times more resistant to antibiotics than free-floating bacteria. Some phages produce enzymes that degrade the protective matrix holding these biofilms together.
Clinical applications are expanding. Phage therapy has reported efficacy rates of 50% to 70% with an excellent safety profile and no serious adverse events. Current uses primarily target multidrug-resistant infections of the lungs, wounds, bloodstream, and urinary tract. In one notable case, a 15-year-old cystic fibrosis patient with an extensively drug-resistant mycobacterial infection achieved significant improvement after treatment with a cocktail of both natural and genetically engineered phages.